The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells

British Journal of Cancer

Volumn 102, Issue 6, 2010, Pages 1052-1060

  Huang, J ^a,b   Chen, K ^a   Chen, J ^b   Gong, W ^c   Dunlop, N M ^a   Howard, O M Z ^a   Gao, Y ^b   Bian, X W ^b   Wang, J M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c SAIC FREDERICK INC   (United States)

Author keywords

Cancer; Formylpeptide receptor; Glioblastoma; Invasion

Indexed keywords

CALCIUM; FORMYLPEPTIDE RECEPTOR; GELATINASE A; GELATINASE B;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASES; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PHENOTYPE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, G-PROTEIN-COUPLED; TRANSPLANTATION, HETEROLOGOUS;

EID: 77949540049     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605591     Document Type: Article

References (32)

1. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Perretti M, Nusrat A (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281(28): 19588-19599
2. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloprotei-nase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10): 737-744
3. Cheng N, He R, Tian J, Dinauer MC, Ye RD (2007) A critical role of protein kinase C delta activation loop phosphorylation in formyl-methionyl- leucyl-phenylalanine-induced phosphorylation of p47(phox) and rapid activation of nicotinamide adenine dinucleotide phosphate oxidase. J Immunol 179(11): 7720-7728
4. Chintala SK, Sawaya R, Aggarwal BB, Majumder S, Giri DK, Kyritsis AP, Gokaslan ZL, Rao JS (1998) Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J Biol Chem 273(22): 13545-13551
5. De Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G (1996) Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol 98(1): 152-164
6. Demuth T, Berens ME (2004) Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 70(2): 217-228
7. Gao JL, Lee EJ, Murphy PM (1999) Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med 189(4): 657-662
8. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21(8): 1624-1636
9. Huang J, Chen K, Gong W, Zhou Y, Le Y, Bian X, Wang JM (2008a) Receptor 'hijacking' by malignant glioma cells: a tactic for tumor progression. Cancer Lett 267(2): 254-261
10. Huang J, Chen K, Huang J, Gong W, Dunlop NM, Howard OM, Bian X, Gao Y, Wang JM (2008b) Regulation of the leukocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation. Carcinogenesis 30(2): 348-355
11. Huang J, Hu J, Bian X, Chen K, Gong W, Dunlop NM, Howard OM, Wang JM (2007) Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res 67(12): 5906-5913
12. Kam AY, Liu AM, Wong YH (2007) Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-kappa B kinase in human U87 astrocytoma cells. J Neurochem 103(4): 1553-1566
13. Le Y, Hu J, Gong W, Shen W, Li B, Dunlop NM, Halverson DO, Blair DG, Wang JM (2000) Expression of functional formyl peptide receptors by human astrocytoma cell lines. J Neuroimmunol 111(1-2): 102-108
14. Le Y, Murphy PM, Wang JM (2002) Formyl-peptide receptors revisited. Trends Immunol 23(11): 541-548
15. Lee HY, Kim MK, Park KS, Bae YH, Yun J, Park JI, Kwak JY, Bae YS (2005) Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem Biophys Res Commun 330(3): 989-998
16. Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2): 329-333
17. McCoy R, Haviland DL, Molmenti EP, Ziambaras T, Wetsel RA, Perlmutter DH (1995) N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med 182(1): 207-217
18. Migeotte I, Riboldi E, Franssen JD, Gregoire F, Loison C, Wittamer V, Detheux M, Robberecht P, Costagliola S, Vassart G, Sozzani S, Parmentier M, Communi D (2005) Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J Exp Med 201(1): 83-93
19. Rabiet MJ, Huet E, Boulay F (2005) Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol 35(8): 2486-2495
20. Rescher U, Danielczyk A, Markoff A, Gerke V (2002) Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol 169(3): 1500-1504
21. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M, Blasi F (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 99(3): 1359-1364
22. Rondepierre F, Bouchon B, Papon J, Bonnet-Duquennoy M, Kintossou R, Moins N, Maublant J, Madelmont JC, D'Incan M, Degoul F (2009) Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta 1794(1): 61-69
23. Southgate EL, He RL, Gao JL, Murphy PM, Nanamori M, Ye RD (2008) Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutro-phils. J Immunol 181(2): 1429-1437
24. Sun R, Iribarren P, Zhang N, Zhou Y, Gong W, Cho EH, Lockett S, Chertov O, Bednar F, Rogers TJ, Oppenheim JJ, Wang JM (2004) Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol 173(1): 428-436
25. Wenzel-Seifert K, Seifert R (1993) Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L- phenylalanine and cyclosporins A, B, C, D, and E. J Immunol 150(10): 4591-4599
26. Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y, Han YL, Chen BS, Wei F, Qian XH, Cai YY, Shen Y, Wu M, Wang MR (2002) Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 21(43): 6641-6648
27. Yabkowitz R, Meyer S, Black T, Elliott G, Merewether LA, Yamane HK (1999) Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood 93(6): 1969-1979
28. Yao XH, Ping YF, Chen JH, Chen DL, Xu CP, Zheng J, Wang JM, Bian XW (2008a) Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR. J Neurooncol 86(1): 47-53
29. Yao XH, Ping YF, Chen JH, Xu CP, Chen DL, Zhang R, Wang JM, Bian XW (2008b) Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J Pathol 215(4): 369-376
30. Zhou Y, Bian X, Le Y, Gong W, Hu J, Zhang X, Wang L, Iribarren P, Salcedo R, Howard OM, Farrar W, Wang JM (2005) Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst 97(11): 823-835
31. Zhou Y, Larsen PH, Hao C, Yong VW (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277(51): 49481-49487
32. Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A (2007) CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 67(7): 3396-3405